Multiple myeloma in central Norway 1981-1982: A randomized clinical trial of 5-drug combination therapy versus standard therapy-Reference-Cited by-同舟云学术

Multiple myeloma in central Norway 1981-1982: A randomized clinical trial of 5-drug combination therapy versus standard therapy

Published:2009-04-24 Issue:3 Volume:37 Page:243-248
ISSN:0036-553X
Container-title:Scandinavian Journal of Haematology
language:en
Short-container-title:

Author:

Kildahl-Andersen O.,Bjark P.,Bondevik A.,Bull O.,Dehli O.,Kvambe V.,Nordahl E.,Ytrehus K.,Lamvik J.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0609.1986.tb02304.x/fullpdf

Reference16 articles.

1. A clinical staging system for multiple myeloma: correlation of measured myeloma cell mass with presenting features, response to treatment, and survival;Durie;Cancer,1975

2. The current status and future prospects of treatment for multiple myeloma;Durie;Clin Haematol,1982

3. Alternating combination chemotherapy and levamisole improves survival in multiple myeloma: A Southwest Oncology Group study;Salmon;J Clin Oncol,1983

4. Progress in the treatment of plasma cell myeloma;Bergsagel;J Clin Oncol,1983

5. Proposed guidelines for protocol studies. II. Plasma cell myeloma;Chronic Leukemia-Myeloma Task Force, National Cancer Institute:;Cancer Chemother Rep,1973

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alternating combination chemotherapy (VMCP/VBAP) is not superior to melphalan/prednisone in the treatment of multiple myeloma patients stage III -A randomized study from MGCS;European Journal of Haematology;2009-04-24

2. Multiple myeloma in central and northern Norway 1981-1982: A follow-up study of a randomized clinical trial of 5-drug combination therapy versus standard therapy;European Journal of Haematology;2009-04-24

3. In vitro synergistic activity of PDN-IFNα and NM + IFNα combinations on fresh bone-marrow samples from multiple myeloma patients;Hematological Oncology;2006-10

4. Melphalan and Prednisone (MP) Regimen for Multiple Myeloma;Hospital Pharmacy;2004-04

5. Adoptive immunotherapy with antigen-specific T cells in myeloma: a model of tumor-specific donor lymphocyte infusion;Seminars in Oncology;2004-02